DeepMed Research

The Sidney Kimmel Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website: http://www.hopkinsmedicine.org/kimmel_cancer_center

Clinical Trials

Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblastoma

Early Phase 1

Terminated

Conditions: Medulloblastoma

Interventions: Drug: Lomustine
Drug: Vincristine
Drug: Cisplatin
Drug: Cyclophosphamide
Drug: Mesna

First Posted Date: 2014-08-08

Last Posted Date: 2021-11-05

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 6

Registration Number: NCT02212574

Locations: 🇺🇸
Ann and Robert H Lurie Children's Hospital of Chicago Hematology/Oncology, Chicago, Illinois, United States
🇺🇸
Children's Hospital Colorado Center for Cancer & Blood Disorders, Aurora, Colorado, United States
🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States

and more 13 locations

Reiki as a Complementary Therapy: A Pilot Study

Not Applicable

Withdrawn

Conditions: Hematologic Malignancy

Interventions: Behavioral: Reiki

First Posted Date: 2014-08-04

Last Posted Date: 2014-12-23

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Registration Number: NCT02207764

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

FBnTP Imaging of Breast Cancer

Phase 1

Terminated

Conditions: Breast Cancer

Interventions: Drug: FBnTP

First Posted Date: 2014-07-30

Last Posted Date: 2021-12-15

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 4

Registration Number: NCT02204462

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy

Phase 2

Active, not recruiting

Conditions: Adenocarcinoma of the Prostate

Interventions: Drug: Enzalutamide
Radiation: SRT

First Posted Date: 2014-07-30

Last Posted Date: 2023-05-31

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 96

Registration Number: NCT02203695

Locations: 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
Karmanos Cancer Center, Detroit, Michigan, United States
🇺🇸
Suburban Hospital, Bethesda, Maryland, United States

and more 6 locations

A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers

Not Applicable

Completed

Conditions: Tobacco Use Disorder
Head and Neck Neoplasms
Radiation
Thoracic Neoplasms

Interventions: Other: Comprehensive smoking cessation intervention
Behavioral: Enhanced usual care

First Posted Date: 2014-07-11

Last Posted Date: 2019-01-17

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 30

Registration Number: NCT02188563

Locations: 🇺🇸
Johns Hopkins Medicine, Baltimore, Maryland, United States

Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme

Phase 2

Recruiting

Conditions: Glioblastoma Multiforme

Interventions: Drug: Temozolomide
Radiation: Subventricular Zone radiation
Radiation: Neural Progenitor Cell Sparing radiation

First Posted Date: 2014-06-27

Last Posted Date: 2024-06-07

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 60

Registration Number: NCT02177578

Locations: 🇺🇸
Sibley Memorial Hospital, Washington, District of Columbia, United States
🇺🇸
The SKCCC at Johns Hopkins, Baltimore, Maryland, United States
🇺🇸
Suburban Hospital, Bethesda, Maryland, United States

Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer

Phase 1

Completed

Conditions: Metastatic Prostate Cancer

Interventions: Drug: 18F-DCFPyL

First Posted Date: 2014-05-30

Last Posted Date: 2020-05-07

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 37

Registration Number: NCT02151760

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Surveillance

Phase 2

Withdrawn

Conditions: Detectable Prostate Nodules

Interventions: Drug: Bicalutamide plus Finasteride- Combination therapy

First Posted Date: 2014-05-26

Last Posted Date: 2017-03-22

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Registration Number: NCT02146937

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

Phase 2

Completed

Conditions: Transplantation, Bone Marrow
Myeloablative Conditioning
HLA-mismatched Bone Marrow Transplantation
Graft Survival

Interventions: Drug: Cyclophosphamide
Radiation: TBI
Drug: Busulfan
Other: Unmanipulated Bone Marrow
Drug: Tacrolimus
Drug: Mycophenolate mofetil

First Posted Date: 2014-04-22

Last Posted Date: 2021-11-26

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 35

Registration Number: NCT02120157

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Washington University in St. Louis, Saint Louis, Missouri, United States
🇨🇦
British Columbia Children's Hospital, Vancouver, British Columbia, Canada

and more 6 locations

A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy

Early Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Drug: Vismodegib

First Posted Date: 2014-04-16

Last Posted Date: 2018-07-20

Lead Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Target Recruit Count: 9

Registration Number: NCT02115828

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy